Patents by Inventor Robin Tyacke

Robin Tyacke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Morpholine-like monoamine releasers
    Patent number: 12595269
    Abstract: Disclosed herein are certain therapeutic substituted heterocyclic bridged ring compounds, including substituted morpholine, thiomorpholine, and piperidine compounds and their homologues, having various advantages over current compounds used in certain methods of drug-assisted therapy, such as MDMA, together with pharmaceutical compositions containing such compounds, and methods of their use to treat mental health disorders and CNS disorders.
    Type: Grant
    Filed: February 16, 2023
    Date of Patent: April 7, 2026
    Assignee: Solvonis Therapeutics Ireland Holdings Limited
    Inventors: Alan Borthwick, Fabrizio Micheli, Alessandra Micoli, Ferruccio Palazzesi, Agostino Cianciulli, Robin Tyacke, David Nutt
  • Short-acting monoamine releasers
    Patent number: 12590077
    Abstract: Disclosed herein are novel 1,3-benzodioxole esters and their homologues, having various advantages over current compounds used in certain methods of drug-assisted therapy, such as MDMA, together with pharmaceutical compositions containing such 1,3-benzodioxole esters, and methods of their use to treat CNS disorders, and in particular mental health disorders.
    Type: Grant
    Filed: January 19, 2023
    Date of Patent: March 31, 2026
    Assignee: Solvonics Therapeutics Ireland Holdings Limited
    Inventors: David Nutt, Alan Borthwick, Robin Tyacke
  • BRIDGED RING COMPOUNDS AND THEIR THERAPEUTIC USE AS CNS AGENTS
    Publication number: 20250179089
    Abstract: Disclosed herein are certain therapeutic substituted heterocyclic bridged ring compounds, including substituted morpholine, thiomorpholine, and piperidine compounds and their homologues, having various advantages over current compounds used in certain methods of drug-assisted therapy, such as MDMA, together with pharmaceutical compositions containing such compounds, and methods of their use to treat mental health disorders and CNS disorders.
    Type: Application
    Filed: February 16, 2023
    Publication date: June 5, 2025
    Inventors: Alan Borthwick, Fabrizio Micheli, Alessandra Micoli, Ferruccio Palazzesi, Agostino Cianciulli, Robin Tyacke, David Nutt
  • 1,3-BENZODIOXOLE ESTERS AND THEIR THERAPEUTIC USE
    Publication number: 20250100990
    Abstract: Disclosed herein are novel 1,3-benzodioxole esters and their homologues, having various advantages over current compounds used in certain methods of drug-assisted therapy, such as MDMA, together with pharmaceutical compositions containing such 1,3-benzodioxole esters, and methods of their use to treat CNS disorders, and in particular mental health disorders.
    Type: Application
    Filed: January 19, 2023
    Publication date: March 27, 2025
    Inventors: David Nutt, Alan Borthwick, Robin Tyacke